UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 88 filers reported holding UTAH MED PRODS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,170,000 | -3.5% | 13,200 | +2.3% | 0.00% | -20.0% |
| Q1 2020 | $1,213,000 | -10.8% | 12,900 | +2.4% | 0.01% | +25.0% |
| Q4 2019 | $1,360,000 | +14.5% | 12,600 | +1.6% | 0.00% | 0.0% |
| Q3 2019 | $1,188,000 | +1.7% | 12,400 | +1.6% | 0.00% | 0.0% |
| Q2 2019 | $1,168,000 | +12.2% | 12,200 | +3.4% | 0.00% | 0.0% |
| Q1 2019 | $1,041,000 | +42.4% | 11,800 | +34.1% | 0.00% | +33.3% |
| Q4 2018 | $731,000 | +6.2% | 8,800 | +20.5% | 0.00% | 0.0% |
| Q3 2018 | $688,000 | -14.4% | 7,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $804,000 | +11.4% | 7,300 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $722,000 | +23.2% | 7,300 | +1.4% | 0.00% | +50.0% |
| Q4 2017 | $586,000 | +3.5% | 7,200 | -6.5% | 0.00% | 0.0% |
| Q3 2017 | $566,000 | +70.0% | 7,700 | +67.4% | 0.00% | +100.0% |
| Q2 2017 | $333,000 | +61.7% | 4,600 | +39.4% | 0.00% | 0.0% |
| Q1 2017 | $206,000 | -14.2% | 3,300 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $240,000 | +110.5% | 3,300 | +73.7% | 0.00% | 0.0% |
| Q3 2016 | $114,000 | – | 1,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 40,000 | $4,000,000 | 5.64% |
| Clean Yield Group | 14,474 | $1,447,000 | 0.46% |
| RICE HALL JAMES & ASSOCIATES, LLC | 113,833 | $11,383,000 | 0.40% |
| Ranger Investment Management | 68,730 | $6,873,000 | 0.38% |
| ISTHMUS PARTNERS, LLC | 17,534 | $1,753,000 | 0.29% |
| Cardinal Capital Management | 10,097 | $1,010,000 | 0.20% |
| GLOBEFLEX CAPITAL L P | 19,420 | $1,942,000 | 0.20% |
| Ancora Advisors LLC | 26,689 | $2,669,000 | 0.06% |
| Penobscot Investment Management Company, Inc. | 4,000 | $400,000 | 0.05% |
| SEIZERT CAPITAL PARTNERS, LLC | 10,430 | $1,043,000 | 0.05% |